数位治疗市场 - 全球与区域分析：分析与预测（2023-2033）

Digital Therapeutic Market - A Global and Regional Analysis: Analysis and Forecast, 2023-2033

出版日期: 按订单生产 | 出版商:

BIS Research | 英文 | 商品交期: 7-10个工作天内

价格

简介目录

数位治疗是指基于证据的治疗性介入，利用数位技术为各种医疗状况的预防、管理和治疗提供医学治疗、干预和支持。

这些数位介入措施旨在改善健康结果，可用作独立治疗方法或与传统医学疗法结合使用。

数位治疗市场通常被称为“DTx”或“数位治疗”，是医疗保健行业快速成长的部分。数位疗法是治疗性介入，使用行动应用程式、软体程式、穿戴式装置和远端医疗解决方案等数位技术，针对各种医疗状况和健康挑战提供医疗治疗和干预措施。

数位治疗市场为组织提供了宝贵的机会，使其医疗保健产品多样化并增强其价值提案。透过将基于证据的数位疗法纳入其产品组合中，医疗保健提供者、製药公司和付款人可以改善患者的治疗结果并提高病人参与。

该报告研究了全球数位治疗市场，并提供了市场概述，包括按产品、应用、销售管道、地区和参与市场的公司概况分類的趋势。

概述
关键策略和发展
市场占有率分析
全球生态系概览
公司简介
- Akili Interactive Labs, Inc.
- Kaia Health
- 2MORROW, Inc.
- Click Therapeutics, Inc.
- Biofourmis Inc
- Glooko, Inc.
- CureApp
- Kaia Health Software GmbH
- HiDoc Technologies GmbH (Cara Care)
- Neurotrack
- Lark Health
- Omada Health, Inc.
- ResMed
- Vida Health
- Vivante Health, Inc.

简介目录

The digital therapeutic market report constitutes an extensive study of the digital therapeutics industry. Digital therapeutics (DTx) refers to evidence-based therapeutic interventions that use digital technologies to deliver medical treatments, interventions, and support for the prevention, management, or treatment of various medical conditions. These digital interventions are designed to improve health outcomes and can be used as standalone treatments or in conjunction with traditional medical therapies.

The key segments are:

By Product
- Software
- Devices

By Application
- Treatment/ Patient Care-related Application
  - Diabetes
  - Neurological Disorder
  - Smoking Cessation
  - Chronic Respiratory Disorders
  - Gastrointestinal Disorder
  - Cardiovascular Diseases
  - Medication Adherence
  - Rehabilitation & Patient Care
  - Others
- Preventive Applications
  - Nutrition Management
  - Lifestyle Management
  - Other

By Sales Channel
- Business-to-Business (B2B)
  - Insurance Providers
  - Corporate Employers
  - Pharmaceutical Companies
  - Others
- Business-to-Consumers
  - Patients
  - Caregivers

The digital therapeutic market is segregated into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Data for each of these regions, along with country-level analysis is provided in the market study.

The key market players in the digital therapeutic market are: Akili Interactive Labs, Inc., HiDoc Technologies GmbH (Cara Care), Click Therapeutics, Inc., ResMed, and 2MORROW, Inc., Omada Health, Inc. among others.

Product Definition

According to BIS Research, the digital therapeutic market, often referred to as "DTx" or "digital therapeutics," is a rapidly growing sector within the healthcare industry. Digital therapeutics are evidence-based therapeutic interventions that use digital technologies, such as mobile apps, software programs, wearable devices, and telehealth solutions, to deliver medical treatments and interventions for various medical conditions and health challenges.

How can this report add value?

The digital therapeutic market presents a valuable opportunity for organizations to diversify their healthcare offerings and enhance their value proposition. By incorporating evidence-based digital therapeutics into their portfolios, healthcare providers, pharmaceutical companies, and insurers can improve patient outcomes and increase patient engagement.

The Digital Therapeutic Market Report is a concise analysis of the rapidly growing market including a snapshot of the current market landscape, covering key trends, opportunities, and challenges. The report also highlights different products, applications, and sales channels of the market such as software and devices. Additionally, the report profiles leading companies and startups in the market, offering insights into their strategies and innovations. With a focus on market size, growth projections, and regional dynamics, the digital therapeutic market report is a valuable resource for manufacturers, distributors, and other pharmaceutical companies.

1. Global Digital Therapeutic Market: Overview

1.1. Product Definition
1.2. Inclusion and Exclusion Criteria
1.3. Key Findings

2. Global Digital Therapeutic Market: Industry Analysis

2.1. Key Trends
2.2. Value Chain Analysis
2.3. Funding Scenario
2.4. Regulatory Framework
2.5. Patent Analysis

3. Global Digital Therapeutic Market: Market Dynamics

3.1. Impact Analysis
3.2. Market Drivers
3.3. Market Restraints
3.4. Market Opportunities

4. Global Digital Therapeutic Market (by Product)

4.1. Overview
4.2. Growth Share Matrix
4.3. Software
4.4. Devices

5. Global Digital Therapeutic Market (by Application)

5.1. Overview
5.2. Growth Share Matrix
5.3. Treatment/ Patient Care-related Application
- 5.3.1. Diabetes
- 5.3.2. Neurological Disorder
- 5.3.3. Smoking Cessation
- 5.3.4. Chronic Respiratory Disorders
- 5.3.5. Gastrointestinal Disorder
- 5.3.6. Cardiovascular Diseases
- 5.3.7. Medication Adherence
- 5.3.8. Rehabilitation & Patient Care
- 5.3.9. Others
5.4. Preventive Applications
- 5.4.1. Nutrition Management
- 5.4.2. Lifestyle Management
- 5.4.3. Other

6. Global Digital Therapeutic Market (by Sales Channel)

6.1. Overview
6.2. Growth Share Matrix
6.3. Business-to-Business (B2B)
- 6.3.1. Insurance Providers
- 6.3.2. Corporate Employers
- 6.3.3. Pharmaceutical Companies
- 6.3.4. Others
6.4. Business-to-Consumers
- 6.4.1. Patients
- 6.4.2. Caregivers

7. Global Digital Therapeutic Market (by Region)

7.1. Overview
7.2. North America
- 7.2.1. Key Findings
- 7.2.2. Market Size and Forecast
  - 7.2.2.1. North America Digital Therapeutics Market, by Product
  - 7.2.2.2. North America Digital Therapeutics Market, by Application
  - 7.2.2.3. North America Digital Therapeutics Market, by Sales Channel
  - 7.2.2.4. North America Digital Therapeutics Market, by Country
    - 7.2.2.4.1. U.S
    - 7.2.2.4.2. Canada
7.3. Europe
- 7.3.1. Key Findings
- 7.3.2. Market Size and Forecast
  - 7.3.2.1. Europe Digital Therapeutics Market, by Product
  - 7.3.2.2. Europe Digital Therapeutics Market, by Application
  - 7.3.2.3. Europe Digital Therapeutics Market, by Sales Channel
  - 7.3.2.4. Europe Digital Therapeutics Market, by Country
    - 7.3.2.4.1. U.K.
    - 7.3.2.4.2. Germany
    - 7.3.2.4.3. France
    - 7.3.2.4.4. Italy
    - 7.3.2.4.5. Spain
    - 7.3.2.4.6. Rest-of-Europe
7.4. Latin America
- 7.4.1. Key Findings
- 7.4.2. Market Size and Forecast
  - 7.4.2.1. Latin America Digital Therapeutics Market, by Product
  - 7.4.2.2. Latin America Digital Therapeutics Market, by Application
  - 7.4.2.3. Latin America Digital Therapeutics Market, by Sales Channel
  - 7.4.2.4. Latin America Digital Therapeutics Market, by Country
    - 7.4.2.4.1. Brazil
    - 7.4.2.4.2. Mexico
    - 7.4.2.4.3. Rest-of-Latin America
7.5. Asia-Pacific
- 7.5.1. Key Findings
- 7.5.2. Market Size and Forecast
  - 7.5.2.1. Asia-Pacific Digital Therapeutics Market, by Product
  - 7.5.2.2. Asia-Pacific Digital Therapeutics Market, by Application
  - 7.5.2.3. Asia-Pacific Digital Therapeutics Market, by Sales Channel
  - 7.5.2.4. Asia-Pacific Digital Therapeutics Market, by Country
    - 7.5.2.4.1. China
    - 7.5.2.4.2. Japan
    - 7.5.2.4.3. India
    - 7.5.2.4.4. Australia
    - 7.5.2.4.5. South Korea
    - 7.5.2.4.6. Rest-of-Asia-Pacific
7.6. Middle East and Africa
- 7.6.1. Key Findings
- 7.6.2. Market Size and Forecast
  - 7.6.2.1. Middle East and Africa Digital Therapeutics Market, by Product
  - 7.6.2.2. Middle East and Africa Digital Therapeutics Market, by Application
  - 7.6.2.3. Middle East and Africa Digital Therapeutics Market, by Sales Channel
  - 7.6.2.4. Middle East and Africa Digital Therapeutics Market, by Country
    - 7.6.2.4.1. K.S.A
    - 7.6.2.4.2. U.A.E.
    - 7.6.2.4.3. Israel
    - 7.6.2.4.4. South Africa
    - 7.6.2.4.5. Rest-of-Middle East and Africa

8. Global Digital Therapeutic Market: Competitive Insights and Company Profile

8.1. Overview
8.2. Key Strategies and Developments
- 8.2.1. Synergistic Activities
- 8.2.2. Regulatory Accreditations
- 8.2.3. Product and Service Launches
- 8.2.4. Acquisitions and Mergers
- 8.2.5. Approvals
8.3. Market Share Analysis
8.4. Global Ecosystem Glimpse
8.5. Company Profiles
- 8.5.1. Akili Interactive Labs, Inc.
  - 8.5.1.1. Company Overview
  - 8.5.1.2. Product Portfolio
  - 8.5.1.3. Recent Developments
  - 8.5.1.4. Analyst Perceptive
- 8.5.2. Kaia Health
- 8.5.3. 2MORROW, Inc.
- 8.5.4. Click Therapeutics, Inc.
- 8.5.5. Biofourmis Inc
- 8.5.6. Glooko, Inc.
- 8.5.7. CureApp
- 8.5.8. Kaia Health Software GmbH
- 8.5.9. HiDoc Technologies GmbH (Cara Care)
- 8.5.10. Neurotrack
- 8.5.11. Lark Health
- 8.5.12. Omada Health, Inc.
- 8.5.13. ResMed
- 8.5.14. Vida Health
- 8.5.15. Vivante Health, Inc.